New DNA Laboratory to Revolutionise Forensic Investigations in Ghana

Ghana has taken a significant step towards strengthening its forensic and health research capabilities with the commissioning of a national Human Identification Laboratory, popularly known as the DNA Laboratory, at the Noguchi Memorial Institute for Medical Research.

The state-of-the-art facility is expected to enhance the country’s ability to solve complex criminal cases, identify victims of disasters, and resolve paternity, maternity and inheritance disputes through advanced DNA analysis conducted locally.

President John Dramani Mahama, who commissioned the laboratory alongside newly established vaccine research and development facilities, described the project as a critical investment in Ghana’s scientific and emergency response infrastructure.

According to the President, the facility addresses a long-standing gap in the country’s forensic capabilities, which has previously forced Ghana to depend on foreign laboratories for specialised DNA testing.

Recalling the aftermath of the August 2025 helicopter crash that claimed eight lives, President Mahama noted that tissue samples had to be transported to South Africa for DNA analysis before victims could be identified.

He described the situation as an unfortunate experience that highlighted the country’s limited forensic capacity at the time.

“With this laboratory in place, Ghana will be able to respond to similar emergencies more quickly, professionally and independently,” he said.

Minister for Health, Kwabena Mintah Akandoh, said the establishment of the DNA laboratory was undertaken following a directive from the President after the helicopter tragedy exposed weaknesses in the nation’s forensic systems.

The Minister explained that while Ghana possesses skilled scientists capable of conducting sophisticated genetic analyses, the country lacked the specialised equipment required to perform DNA testing domestically.

He added that the accompanying vaccine research laboratories would play a key role in developing local expertise for vaccine production and advancing Ghana’s pharmaceutical manufacturing sector.

According to Mr Akandoh, the first vaccines bottled in Ghana are expected to reach the market by 2027.

Chief Executive Officer of the National Vaccine Institute, Dr Sodzi Sodzi-Tettey, said the country was steadily progressing towards the creation of a sustainable vaccine manufacturing ecosystem.

He disclosed that the first of three bulk substances required for the planned vaccine production programme had already arrived in Ghana and was currently being held at Atlantic LifeSciences.

Dr Sodzi-Tettey further revealed that the government was pursuing long-term procurement arrangements to ensure a reliable market for vaccines produced locally.

The newly commissioned DNA laboratory and vaccine research facilities form part of a broader national strategy aimed at building domestic scientific capacity, enhancing health security and reducing Ghana’s dependence on foreign expertise and imported medical supplies.

The projects are also expected to position Ghana as a regional leader in biomedical research, forensic science and vaccine innovation while improving the country’s preparedness to respond to public health and emergency challenges.